Hirokazu Saitoh

Electrical and mechanical alternans in canine myocardium in vivo. Dependence on intracellular calcium cycling.

BackgroundElectrical and mechanical alternans are thought to result from a common cellular mechanism. To confirm this phenomenon in vivo and extend our understanding, we investigated the effects of temperature, verapamil, and caffeine on alternans in intact beating hearts. Methods and ResultsWe recorded surface ECG, monophasic action potential (MAP) using suction electrodes, and left ventricular pressure (LVP). Alternans of MAP configurations and of LVP were evaluated in 20 dogs. MAPs were recorded from the apex, base, and midportion of the left ventricle with LVP. The hearts were driven from the left ventricular apex at a basic cycle length of 1000 milliseconds, and alternans was induced with an abrupt shortening of the cycle length to 400 milliseconds. MAPD30/100, the ratio between the MAP durations (MAPD) at 30%o and 100% repolarization levels, was measured as an index ofMAP configuration. The magnitude ofMAP or LVP alternans was defined as the difference in MAPD30/100 or in LVP between the fifth and sixth paced beats. The magnitude of MAP alternans differed by recording site but correlated with activation time. Lowering the temperature increased the magnitude. MAP alternans was always associated with LVP alternans under control conditions. Verapamil significantly attenuated the magnitude of MAP alternans but did not change that of LVP alternans. Caffeine attenuated the magnitude of both MAP and LVP alternans. T wave alternans was suppressed by verapamil or caffeine. ConclusionActivation time is one of the factors modifying electrical alternans. Delayed intracellular Ca2 cycling plays a role in the concomitant occurrence of electrical and mechanical alternans.

Pharmacokinetics of landiolol hydrochloride, a new ultra‐short‐acting β‐blocker, in patients with cardiac arrhythmias

To elucidate pharmacokinetics and pharmacodynamics of landiolol hydrochloride, newer developed ultra‐short‐acting β‐blocker, in patients with various cardiac tachyarrhythmias.

Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias.

Whether phosphodiesterase inhibitors increase the heart rate in patients with bradyarrhythmias is not known. We attempted to determine whether the oral phosphodiesterase inhibitor cilostazol exhibits beneficial chronotropic effects in patients with symptomatic bradyarrhythmias. Twenty patients comprising eight with bradycardic atrial fibrillation, eight with sick sinus syndrome, and four with Wenckebach-type atrioventricular block, whose 24-h total heart-beat count was < or =70,000 beats and whose maximal RR interval was > or =2.5 s, were enrolled. Holter recordings (24-h) were made before and 2 weeks after oral daily administration of 200 mg of cilostazol. Cilostazol increased the 24-h total heart-beat count from 77,429 +/- 11,168 to 107,981 +/- 13,536 (95% confidence interval, 24,605-36,497; p < 0.0001), the minimal heart rate from 33 +/- 9 47 +/- 13 beats/min (95% confidence interval, 9-19 beats/min; p < 0.0001), and the maximal RR interval from 3,149 +/- 1,018 to 2,087 +/- 601 ms (95% confidence interval, -1,517 to -608 ms; p = 0.0001). Only two patients had headaches as adverse effects. In conclusion, cilostazol had a beneficial positive chronotropic effect in patients with bradyarrhythmias, especially with bradycardic atrial fibrillation and sick sinus syndrome.

Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class 1c antiarrhythmic agent

To establish the clinical efficacy of pilsicainide, we evaluated its electrophysiologic and hemodynamic effects after a single oral administration to 18 patients with documented supraventricular tachycardia (SVT). To determine the minimal effective blood level, changes in efficacy with time were evaluated by serial reinduction studies with venous blood sampling for measurement of the plasma pilsicainide level. Sixty minutes after administration of a single oral dose of pilsicainide, the sinoatrial conduction time, AH and HV intervals, and the effective refractory period of the right ventricle were prolonged. Ventriculoatrial conduction was blocked in 11 patients [nine of 12 via accessory pathway and two of six via the atrioventricular (AV) node], resulting in the suppression of SVT induction in nine of 13 patients. Pilsicainide increased the heart rate and mean pulmonary arterial pressure and decreased the stroke volume index at 60 min. PQ interval, QRS width, and QTc were significantly prolonged after pilsicainide, and the percentage prolongations of the PQ interval were well correlated with the plasma pilsicainide levels. The plasma level effective for suppression of SVT was considered to be >0.5 microg/ml. We concluded that a single oral administration of pilsicainide is well tolerated and effective in suppressing SVT.

Mutual information discloses relationship between hemodynamic variables in artificial heart-implanted dogs

A mutual information (MI) method for assessment of the relationship between hemodynamic variables was proposed and applied to the analysis of heart rate (HR), arterial blood pressure (BP), and renal sympathetic nerve activity (RSNA) in artificial heart-implanted dogs to quantify correlation between these parameters. MI measures the nonlinear as well as linear dependence of two variables. Simulation studies revealed that this MI technique furnishes mathematical features well suited to the investigation of nonlinear dynamics such as the cardiovascular system and can quantify a relationship between two parameters. To constitute a model free of the natural heart, two pneumatically actuated ventricular assist devices were implanted as biventricular bypasses in acute canine experiments. RSNA was detected with the use of bipolar electrodes attached to the renal sympathetic nerve. Analysis of data during control revealed that correlation between HR and RSNA was higher than that between HR and BP and that between RSNA and BP ( P < 0.05). Although RSNA seemed to fluctuate noncorrelatedly with BP in higher pacing rates, the MI values between them disclosed their strong correlation. Surprisingly, correlation between RSNA and BP was stronger during a pacing rate of 60 beats/min than during higher pacing rates and control ( P < 0.05). It is suggested that the baroreflex system may be susceptible to pacing rates during the total artificial heart state. We calculated the time delay between HR and RSNA, between RSNA and BP, and between HR and BP by regarding a time delay at which the maximum MI value between each pair of parameters was given as a physiological delay. Our results indicate that RSNA leads BP, BP leads HR, and RSNA leads HR during control ( P < 0.05). We conclude that this method could provide a powerful means for measuring correlation of physiological variables.A mutual information (MI) method for assessment of the relationship between hemodynamic variables was proposed and applied to the analysis of heart rate (HR), arterial blood pressure (BP), and renal sympathetic nerve activity (RSNA) in artificial heart-implanted dogs to quantify correlation between these parameters. MI measures the nonlinear as well as linear dependence of two variables. Simulation studies revealed that this MI technique furnishes mathematical features well suited to the investigation of nonlinear dynamics such as the cardiovascular system and can quantify a relationship between two parameters. To constitute a model free of the natural heart, two pneumatically actuated ventricular assist devices were implanted as biventricular bypasses in acute canine experiments. RSNA was detected with the use of bipolar electrodes attached to the renal sympathetic nerve. Analysis of data during control revealed that correlation between HR and RSNA was higher than that between HR and BP and that between RSNA and BP (P < 0.05). Although RSNA seemed to fluctuate noncorrelatedly with BP in higher pacing rates, the MI values between them disclosed their strong correlation. Surprisingly, correlation between RSNA and BP was stronger during a pacing rate of 60 beats/min than during higher pacing rates and control (P < 0. 05). It is suggested that the baroreflex system may be susceptible to pacing rates during the total artificial heart state. We calculated the time delay between HR and RSNA, between RSNA and BP, and between HR and BP by regarding a time delay at which the maximum MI value between each pair of parameters was given as a physiological delay. Our results indicate that RSNA leads BP, BP leads HR, and RSNA leads HR during control (P < 0.05). We conclude that this method could provide a powerful means for measuring correlation of physiological variables.

Developmental Changes of α1-Adrenergic Chronotropic Action on Human Sinus Node

The important role of α 1 -adrenergic receptors in the genesis of cardiac arrhythmias in ischemia and during reperfusion 1 , 2 has recently been elucidated. On the other hand, α 1 -adrenergic modulation of cardiac rhythm has promoted interest in myocardial α 1 -adrenoceptor research. The chronotropic action of α 1 -adrenergic stimulation is usually reported as inhibitory rather than excitatory. 3 However, in some species and in certain tissues, the positive chronotropic action of α 1 -adrenergic stimulation has also been reported. Moreover, there is an important developmental component to the α 1 -adrenergic receptor-effector system. Although α 1 -adrenergic stimulation decreases automaticity in the human atrium and in the ventricular conducting system of the adult rat, 4 , 5 an increase in automaticity brought about by α 1 adrenergic stimulation was reported in isolated neonatal canine Purkinje fibers. 6 These findings suggest that the chronotropic response of cardiac tissues to α 1 -adrenergic stimulation changes from excitatory to inhibitory during development. This study clarifies the effect of α 1 -adrenergic stimulation on human sinus node automaticity, especially in relation to age.

Clinical and electrophysiologic effects of dofetilide in patients with supraventricular tachyarrhythmias.

The clinical and electrophysiologic effect of intravenous dofetilide was evaluated in patients with paroxysmal atrial fibrillation (AF) of recent onset (< 7 days) and paroxysmal supraventricular tachycardia (PSVT). From 2.5 to 5.0 micrograms/kg of dofetilide was administered intravenously for the termination of arrhythmias. For the electrophysiologic study (EPS), 3.0 micrograms for loading and subsequently 2 micrograms/kg was injected for 45 min as a maintenance dose. The EPSs were performed before the loading and during the maintenance dose. AF was successfully converted to sinus rhythm in seven (54%) of 13 patients. The duration of AF from its onset was significantly shorter in responders than that of nonresponders (p < 0.05). Dofetilide also terminated PSVT in four of six patients. In the EPS, dofetilide proportionately lengthened the effective refractory period of the atrium, ventricle, and the accessory pathways without slowing of the intracardiac conduction. Dofetilide completely suppressed the induction of PSVT in seven of 13 patients, restricted the induction zone in five, and inhibited perpetuation of the arrhythmia in the remaining one. The cycle length of PSVT remained unchanged after dofetilide. These results imply that the suppression of the development and maintenance of reentrant arrhythmias may result from the lengthening effect of dofetilide on the refractoriness and the consequent elimination of the excitable gap at the critical part of the reentrant loop.

Clinical effects and pharmacokinetics of a single oral dose of pirmenol hydrochloride

To establish the clinical efficacy of a single oral dose of pirmenol, we evaluated electrophysiologic and hemodynamic effects simultaneously after drug administration, performing electrophysiologic testing in 20 patients with ECG-documented paroxysmal supraventricular tachycardia (PSVT) before and after a single oral 200-mg dose of pirmenol. Hemodynamic measurements were made with a Swan-Ganz catheter in the first 10 consecutive patients. In a different series of patients, we administered a single 200-mg oral dose of pirmenol to evaluate its acute termination effect in 7 patients with PSVT and 9 with paroxysmal atrial fibrillation. Pirmenol prolonged the refractory period of the retrograde conduction system in patients with or without an accessory pathway, and supraventricular tachycardia was no longer inducible at 60 min in 11 patients [8 of 11 with atrioventricular (AV) reentrant tachycardia and 3 of 5 with AV nodal reentrant tachycardia]. Pirmenol increased the heart rate (p < 0.01) and total systemic resistance (p < 0.05), and reduced the stroke volume index (p < 0.01), all significantly. The plasma concentration of pirmenol at 1 h after administration was 0.75 +/- 0.48 microgram/ml. A single oral dose of pirmenol during tachyarrhythmia successfully restored sinus rhythm in 4 of 7 (57%) patients with PSVT and 4 of 9 (44%) patients with paroxysmal atrial fibrillation. A single oral dose of pirmenol was well tolerated as episodic treatment in patients with supraventricular tachyarrhythmias.

A Case of Cardiac Foreign Bodies Associated with Four Types of Tachycardias

A case of cardiac foreign bodies leading to development of four varieties of automatic tachycardia is reported. A 51‐year‐old male with aortic regurgitation was admitted to our hospital because of palpitations. An electrocardiogram revealed junctional tachycardia with or without left bundle branch block, and two types of fascicular tachycardias. Computed tomography showed metallic foreign bodies from a fractured guidewire in the membranous portion of the interventricular septum, which was inadvertently retained when he underwent diagnostic cardiac catheterization at the age of 27.

An inflammatory abdominal aortic aneurysm presenting with acute dissection of the descending thoracic aorta. A case report

A sixty-five-year-old woman had an inflammatory abdominal aortic aneurysm that was complicated by acute dissection of the descending thoracic aorta. The authors emphasize the diagnostic value of dynamic computed tomographic scanning in inflammatory aneurysms and discuss the possible mechanisms for the association of the two conditions.